Search

Most children face pressures growing up — including from their parents and peers. Vik Gill wrestled with circumstances “that may sound more familiar to any child of first-generation immigrants.

… Friday, May 6, 2022 Most children face pressures growing up — including from their parents and peers. Vik Gill wrestled with circumstances “that may sound more familiar to any child of first-generation immigrants,” he says “I was raised in a pretty culturally Indian household,” says Vik, an analyst for

A multicenter team led by Memorial Sloan Kettering neurologist and researcher Ingo K. Mellinghoff has uncovered the relationship between two proteins that play a critical role in glioblastoma, the most common form of brain cancer.

… Thursday, July 1, 2010 Summary A multicenter team led by Memorial Sloan Kettering neurologist and researcher Ingo K. Mellinghoff has uncovered the relationship between two proteins that play a critical role in glioblastoma, the most common form of brain cancer. A multicenter team led by Memorial Sloan

Hartford Healthcare system in Connecticut has been selected as the first MSK Cancer Alliance member, established to enhance delivery of care, improve patient outcomes, and advance research.

… Tuesday, September 17, 2013 Summary Hartford Healthcare system in Connecticut has been selected as the first MSK Cancer Alliance member, established to enhance delivery of care, improve patient outcomes, and advance research. Memorial Sloan Kettering today launched a transformative initiative to improve

Scott Stuart, Chair of the Boards of Trustees and Governing Trustees at Memorial Sloan Kettering Cancer Center (MSK), has been recognized as a Notable Nonprofit Board Leader in the 2023 Crain’s New York Business special editorial feature.

… Tuesday, October 10, 2023 Scott Stuart, Chair of the Boards of Trustees and Governing Trustees at Memorial Sloan Kettering Cancer Center (MSK), has been recognized as a Notable Nonprofit Board Leader in the 2023 Crain’s New York Business special editorial feature. This list honors exceptional nonprofit

Dr. Mara Sherman's lab at the Sloan Kettering Institute is “all pancreas, all the time.” Learn how her research program is illuminating interactions between cancer cells and the dense weave of fibrous cells that surrounds and protects pancreatic tumors.

… Monday, June 24, 2024 While the overall five-year survival rate for pancreatic cancer is slowly improving, it remains discouragingly low — just 13%, according to the American Cancer Society . And the odds are even worse if the cancer is discovered after it has spread to other organs. Dr. Mara Sherman

IBM, WellPoint, Inc., and Memorial Sloan Kettering Cancer Center today unveiled the first commercially developed Watson-based cognitive computing breakthroughs. These innovations stand alone to help transform the quality and speed of care delivered to patients through individualized, evidence-based medicine.

… Friday, February 8, 2013 IBM (NYSE: IBM ), WellPoint, Inc. (NYSE: WLP ), and Memorial Sloan Kettering Cancer Center today unveiled the first commercially developed Watson-based cognitive computing breakthroughs. These innovations stand alone to help transform the quality and speed of care delivered to

Researchers at Memorial Sloan Kettering Cancer Center have found that change in PSA levels over time - known as PSA velocity - is a poor predictor of prostate cancer and may lead to many unnecessary biopsies.

… Thursday, February 24, 2011 Screening for PSA Velocity Leads to Many Unnecessary Biopsies and Should Be Removed from Screening Guidelines Researchers at Memorial Sloan Kettering Cancer Center have found that change in PSA levels over time — known as PSA velocity — is a poor predictor of prostate cancer

Carol Morris, MD, MS, has assumed the position of Chief of the Orthopaedic Surgery Service at Memorial Sloan Kettering Cancer Center (MSK).

… Friday, October 14, 2022 Carol Morris, MD, MS, has assumed the position of Chief of the Orthopaedic Surgery Service at Memorial Sloan Kettering Cancer Center (MSK). A skilled surgeon and talented leader, Dr. Morris has a deep familiarity with MSK, having previously spent 14 years at the institution as

Memorial Sloan Kettering researchers helped to identify a key insight into what first goes wrong in the development of many leukemias.

… Thursday, June 30, 2011 Researchers at Memorial Sloan Kettering Cancer Center and New York University have discovered how a mutation in the gene known as TET2 contributes to the development of some leukemias . When a mutation in TET2 occurs, it enhances the function of blood stem cells in the bone marrow

Learn about Jakki Stout’s journey from MSK nurse practitioner to breast cancer patient and back to being an even more helpful and inspiring nurse at MSK.

… Monday, June 10, 2024 It’s easy to see that nurse practitioner Jaclyn Stout has a true passion for nursing. Jakki, as she’s called, is a skilled and compassionate caregiver who’s been at Memorial Sloan Kettering Cancer Center (MSK) for 10 years. She loves her work caring for surgery patients recovering